Funding for this research was provided by:
National Natural Science Foundation of China (81572039)
Shanghai Science and Technology Commission (16411961300)
Shanghai Science and Technology Commission (17DZ2293300)
Shanghai Science and Technology Commission (YDZX20193100002868)
Clinical Research Plan of SHDC (16CR3111B)
Clinical Research Plan of SHDC (16CR1029B)
National megaproject on key infectious diseases (2017ZX10202102-001-007)
Article History
Received: 18 October 2021
Accepted: 25 May 2022
First Online: 4 June 2022
Declarations
:
: This study was approved by the ethical review committee of Shanghai Skin Disease Hospital (Shanghai, China; approval number: 2022-07).
: Not applicable.
: The authors declare that they have no conflict of interests.